(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INTEGRILIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INTEGRILIN

ST13

US500000075009658

Class

5

Filing

75009658

Registration

2234543

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

04/23/2019

Trademark type

Word

Nice classes

5

Filing date

10/11/1995

Registration date

03/23/1999

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/23/2019

Last transaction

04/23/2019

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

1996-02-00

First use in commerce

1996-02-00

Drawing code

1

Owner type

03

Owner location

CAMBRIDGE, MA, US

Examiner

DALIER,JOHN DAVID

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MILLENNIUM PHARMACEUTICALS, INC.
COR Therapeutics, Inc.

Representatives

Nancy DiConza FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceuticalsnamely cardiovascular preparations

Publications

History of USPTO decisions and trademark events.

32 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/23/2019

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

04/23/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/23/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/23/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

03/21/2019

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

04/05/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/31/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/14/2008

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/14/2008

PLGL

ASSIGNED TO PARALEGAL

05/06/2008

E89R

TEAS SECTION 8 & 9 RECEIVED

04/24/2008

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/08/2005

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

01/27/2005

MAIL

PAPER RECEIVED

01/27/2005

R.PR

REGISTERED-PRINCIPAL REGISTER

03/23/1999

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/30/1999

DOCK

ASSIGNED TO EXAMINER

01/28/1999

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/19/1999

EX2G

SOU EXTENSION 2 GRANTED

01/19/1999

IUAF

USE AMENDMENT FILED

12/21/1998

EXT2

SOU EXTENSION 2 FILED

12/21/1998

EX1G

SOU EXTENSION 1 GRANTED

07/29/1998

EXT1

SOU EXTENSION 1 FILED

07/02/1998

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

01/06/1998

OP.T

OPPOSITION TERMINATED NO. 999999

10/16/1997

OP.D

OPPOSITION DISMISSED NO. 999999

10/16/1997

OP.I

OPPOSITION INSTITUTED NO. 999999

08/08/1996

OPPF

OPPOSITION PAPERS RECEIVED AT TTAB

07/23/1996

PUBO

PUBLISHED FOR OPPOSITION

06/25/1996

NPUB

NOTICE OF PUBLICATION

05/24/1996

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/13/1996

DOCK

ASSIGNED TO EXAMINER

04/12/1996

Continuous trademark protection

Get notified about every new filing that threatens INTEGRILIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.